Evidence map›Paper›PMID 39860336›Full record

ReviewJournal of clinical medicine2025

Managing Retinitis Pigmentosa: A Literature Review of Current Non-Surgical Approaches.

Leonardo Colombo, Jacopo Baldesi, Salvatore Martella, Chiara Quisisana, Aleksei Antico, Luca Mapelli, Stefania Montagner, Alberto Primon, Luca Rossetti

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Leonardo ColomboEye Clinic, ASST Santi Paolo e Carlo Hospital, University of Milan, 20142 Milan, Italy.ORCID 0000-0002-9556-994X
Jacopo BaldesiEye Clinic, ASST Santi Paolo e Carlo Hospital, University of Milan, 20142 Milan, Italy.
Salvatore MartellaEye Clinic, ASST Santi Paolo e Carlo Hospital, University of Milan, 20142 Milan, Italy.ORCID 0009-0005-8336-1833
Chiara QuisisanaEye Clinic, ASST Santi Paolo e Carlo Hospital, University of Milan, 20142 Milan, Italy.
Aleksei AnticoEye Clinic, ASST Santi Paolo e Carlo Hospital, University of Milan, 20142 Milan, Italy.
Luca MapelliEye Clinic, ASST Santi Paolo e Carlo Hospital, University of Milan, 20142 Milan, Italy.
Stefania MontagnerEye & Vision-Visual Rehabilitation Center, 20128 Milan, Italy.
Alberto PrimonEye & Vision-Visual Rehabilitation Center, 20128 Milan, Italy.
Luca RossettiEye Clinic, ASST Santi Paolo e Carlo Hospital, University of Milan, 20142 Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinitis pigmentosa (RP) is a heterogeneous group of inherited retinal diseases characterized by the progressive loss of photoreceptor function, visual impairment, and, ultimately, blindness. While gene therapy has emerged as a promising therapy, it is currently available only for the RPE65 gene mutation, leaving many patients without targeted genetic treatments. Non-surgical interventions may help in managing the progression of RP and improving patients' quality of life. Visual training and rehabilitation, maximizing residual vision, have shown potential in improving mobility and patients' ability to perform daily activities. Visual aids enhance visual function. Moreover, photo-protection demonstrated effectiveness in mitigating light-induced damage and improving visual comfort. Alternative therapies (i.e., electrostimulation, acupuncture, and ozone therapy) are being explored to preserve retinal function and reduce disease progression. Pharmacological interventions supported by nutritional and psychological counseling play a role in slowing retinal degeneration while managing the emotional burden of progressive vision loss. Although for these interventions, further validation is required, their potential benefits make them valuable additions to care for RP patients. The integration of these interventions into a multidisciplinary care approach-including ophthalmologists, orthoptist, dietitians, and psychologists-is essential for providing comprehensive, personalized care to RP patients while awaiting more widespread gene therapy solutions.

Indexed as

multidisciplinary approachnon-surgical interventionsretinitis pigmentosavisual rehabilitation

Identifiers

PMID39860336
PMCPMC11765533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.